Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension

NCT ID: NCT01127139

Last Updated: 2012-05-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3828 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-04-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The fixed combination of verapamil SR/trandolapril (Tarka®) is an effective, well-tolerated therapy for the treatment of essential hypertension in those who require more than one agent to achieve optimal blood pressure (BP) control. The endpoint is compliance with Tarka® treatment by number/percentage of patients continued on fixed combination Tarka therapy after six months. This Post Marketing Observational Study will be conducted in a prospective, single-arm, single-country, multicenter format. The investigational sites will be the cardiologists, the doctors of internal medicine and general practicians. Since this will be a Post Marketing Observational Study, Tarka® will be prescribed in usual manner in accordance with the terms of the local market authorization with regards to dose, population and indication as well as the local guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Follow-up of patients enables 4 patient visits during this period. For these reasons, the most likely visits are defined as "Inclusion visit" at which treatment with Tarka® is to be initiated, and then "Follow-up visit Week 4-6", "Follow-up visit Month 3 " and "Follow-up visit Month 6", although dates will depend only on the decision of the physician. For these reasons, the most likely visits are defined as "S/V" (Screening Visit), "F1" (Follow-up 1), "F2" (Follow-up 2), "F3" (Follow-up 3). The end point is compliance with Tarka® treatment by number/percentage of patients continued on fixed combination Tarka therapy after six months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Essential Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Czech patients with essential hypertension

Czech hypertensive patients (women and men) with systolic blood pressure (SBP) ≥ 140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg who can be treated with fixed-combination Tarka®.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men, women more than 18 years
* Patients with uncontrolled essential hypertension eligible to Tarka treatment according to local label (BP ≥ 140/90 mmHg)
* Patients providing oral informed consent (including consent of their medical data to be used for a Post Marketing Observational Study) and cooperating with physician
* Patients who never received Tarka® in the past
* Patients whom Tarka® will be prescribed according to the labelled indication and dose

Exclusion Criteria

* Patients contraindicated for treatment of Tarka® according to the local Summary of Product Characteristics (SmPC):
* Hypersensitive to the active substances or to any of the inactive ingredients
* With cardiogenic shock
* With second and third degree atrioventricular block - except in patients with a functioning artificial pacemaker
* With sick sinus syndrome - except in patients with a functioning artificial pacemaker
* With atrial fibrillation/flutter and concomitant Wolff-Parkinson-White syndrome
* With existing history of angioedema associated with administration of an ACE inhibitor
* With severe renal (creatinine clearance \< 10 ml/min) or severe liver impairment (cirrhosis with ascites)
* Pregnant women, women of childbearing potential who are unwilling to use contraception
* Lactating women
* Patients who have participated in clinical studies within the last month or who are currently enrolled in clinical studies
* Patients currently treated with other fixed antihypertensive combination
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Abbott

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam Hloska, M.D.

Role: STUDY_DIRECTOR

Abbott

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Site Reference ID/Investigator# 44896

Babice, , Czechia

Site Status

Site Reference ID/Investigator# 40910

Beroun, , Czechia

Site Status

Site Reference ID/Investigator# 40908

Bílovec, , Czechia

Site Status

Site Reference ID/Investigator# 38816

Blansko, , Czechia

Site Status

Site Reference ID/Investigator# 41189

Brandýs nad Labem, , Czechia

Site Status

Site Ref # / Investigator 40958

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 40821

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 40944

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 41112

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 41187

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 41196

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 44887

Brno, , Czechia

Site Status

Site Reference ID/Investigator# 42083

Brumov, , Czechia

Site Status

Site Reference ID/Investigator# 40967

Bruntál, , Czechia

Site Status

Site Reference ID/Investigator# 40918

Břeclav, , Czechia

Site Status

Site Reference ID/Investigator# 41119

Buštěhrad, , Czechia

Site Status

Site Reference ID/Investigator# 41195

Buštěhrad, , Czechia

Site Status

Site Reference ID/Investigator# 38836

Bystřice nad Pernštejnem, , Czechia

Site Status

Site Reference ID/Investigator# 41190

Bystřice nad Pernštejnem, , Czechia

Site Status

Site Ref # / Investigator 41626

C. Trebova, , Czechia

Site Status

Site Reference ID/Investigator# 42082

Cheb, , Czechia

Site Status

Site Reference ID/Investigator# 41191

České Budějovice, , Czechia

Site Status

Site Ref # / Investigator 38710

České Budějovice, , Czechia

Site Status

Site Reference ID/Investigator# 40948

České Budějovice, , Czechia

Site Status

Site Reference ID/Investigator# 40960

České Budějovice, , Czechia

Site Status

Site Reference ID/Investigator# 40914

České Budějovice, , Czechia

Site Status

Site Reference ID/Investigator# 57305

České Budějovice, , Czechia

Site Status

Site Reference ID/Investigator# 38886

Děčín, , Czechia

Site Status

Site Reference ID/Investigator# 41110

Děčín, , Czechia

Site Status

Site Reference ID/Investigator# 40818

Děčín, , Czechia

Site Status

Site Reference ID/Investigator# 40897

Děčín, , Czechia

Site Status

Site Ref # / Investigator 40902

Děčín, , Czechia

Site Status

Site Reference ID/Investigator# 41117

Hadačka, , Czechia

Site Status

Site Reference ID/Investigator# 40808

Havirov,Ostrava, , Czechia

Site Status

Site Reference ID/Investigator# 41103

Havířov, , Czechia

Site Status

Site Reference ID/Investigator# 40909

Horní Slavkov, , Czechia

Site Status

Site Reference ID/Investigator# 41185

Hradec Králové, , Czechia

Site Status

Site Reference ID/Investigator# 41188

Hradec Králové, , Czechia

Site Status

Site Reference ID/Investigator# 41197

Hranice, , Czechia

Site Status

Site Reference ID/Investigator# 40805

Hranice, , Czechia

Site Status

Site Reference ID/Investigator# 40815

Hranice U Asa, , Czechia

Site Status

Site Reference ID/Investigator# 38736

Jihlava, , Czechia

Site Status

Site Reference ID/Investigator# 38844

Karlovy Vary, , Czechia

Site Status

Site Reference ID/Investigator# 41184

Kdyně, , Czechia

Site Status

Site Reference ID/Investigator# 41113

Kladno, , Czechia

Site Status

Site Ref # / Investigator 44894

Kladno, , Czechia

Site Status

Site Reference ID/Investigator# 40905

Kopřivnice, , Czechia

Site Status

Site Ref # / Investigator 40961

Krnov, , Czechia

Site Status

Site Reference ID/Investigator# 40901

Kunovice, , Czechia

Site Status

Site Reference ID/Investigator# 41192

Kutná Hora, , Czechia

Site Status

Site Reference ID/Investigator# 40811

Litomyšl, , Czechia

Site Status

Site Reference ID/Investigator# 41106

Litvínov, , Czechia

Site Status

Site Reference ID/Investigator# 40904

Louny, , Czechia

Site Status

Site Reference ID/Investigator# 40969

Lovosice, , Czechia

Site Status

Site Reference ID/Investigator# 40953

Malšice, , Czechia

Site Status

Site Reference ID/Investigator# 41204

Mladá Boleslav, , Czechia

Site Status

Site Ref # / Investigator 44882

Mladá Boleslav, , Czechia

Site Status

Site Reference ID/Investigator# 40804

Mnichovo Hradiště, , Czechia

Site Status

Site Ref # / Investigator 41118

Nový Jičín, , Czechia

Site Status

Site Reference ID/Investigator# 40954

Nový Jičín, , Czechia

Site Status

Site Ref # / Investigator 38569

Nymburk, , Czechia

Site Status

Site Reference ID/Investigator# 41114

Olomouc, , Czechia

Site Status

Site Reference ID/Investigator# 40949

Olomouc, , Czechia

Site Status

Site Reference ID/Investigator# 41107

Olomouc, , Czechia

Site Status

Site Ref # / Investigator 40907

Olomouc, , Czechia

Site Status

Site Reference ID/Investigator# 41202

Orlová, , Czechia

Site Status

Site Reference ID/Investigator# 40816

Ostrava, , Czechia

Site Status

Site Reference ID/Investigator# 40951

Ostrava, , Czechia

Site Status

Site Reference ID/Investigator# 40972

Ostrava, , Czechia

Site Status

Site Reference ID/Investigator# 41194

Ostrava, , Czechia

Site Status

Site Reference ID/Investigator# 40968

Ostrava, , Czechia

Site Status

Site Reference ID/Investigator# 40945

Pardubice, , Czechia

Site Status

Site Reference ID/Investigator# 40957

Pardubice, , Czechia

Site Status

Site Reference ID/Investigator# 41201

Pardubice, , Czechia

Site Status

Site Reference ID/Investigator# 41205

Pardubice, , Czechia

Site Status

Site Reference ID/Investigator# 41625

Pardubice, , Czechia

Site Status

Site Reference ID/Investigator# 40956

Pilsen, , Czechia

Site Status

Site Reference ID/Investigator# 40896

Pilsen, , Czechia

Site Status

Site Ref # / Investigator 46282

Pilsen, , Czechia

Site Status

Site Reference ID/Investigator# 40900

Plasy, , Czechia

Site Status

Site Reference ID/Investigator# 41111

Poděbrady, , Czechia

Site Status

Site Ref # / Investigator 40911

Prachatice, , Czechia

Site Status

Site Reference ID/Investigator# 41120

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 41108

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40822

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 44886

Prague, , Czechia

Site Status

Site Ref # / Investigator 40819

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40817

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40812

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 38628

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 44883

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 41193

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 44884

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40917

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40913

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 41123

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 41124

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40903

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 38630

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40802

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 40823

Prague, , Czechia

Site Status

Site Reference ID/Investigator# 41126

Přelouč, , Czechia

Site Status

Site Reference ID/Investigator# 41198

Přelouč, , Czechia

Site Status

Site Reference ID/Investigator# 40809

Příbram, , Czechia

Site Status

Site Reference ID/Investigator# 40952

Rokycany, , Czechia

Site Status

Site Reference ID/Investigator# 44893

Slaný, , Czechia

Site Status

Site Reference ID/Investigator# 41109

Slatiňany, , Czechia

Site Status

Site Reference ID/Investigator# 40919

Smržovka, , Czechia

Site Status

Site Ref # / Investigator 40807

Stará Paka, , Czechia

Site Status

Site Reference ID/Investigator# 40814

Staré Město, , Czechia

Site Status

Site Reference ID/Investigator# 42085

Staré Město, , Czechia

Site Status

Site Reference ID/Investigator# 41104

Sternberk, , Czechia

Site Status

Site Reference ID/Investigator# 38746

Svitavy, , Czechia

Site Status

Site Reference ID/Investigator# 41121

Tábor, , Czechia

Site Status

Site Ref # / Investigator 40820

Teplice, , Czechia

Site Status

Site Reference ID/Investigator# 41203

Tranovice, , Czechia

Site Status

Site Reference ID/Investigator# 40895

Trutnov, , Czechia

Site Status

Site Reference ID/Investigator# 38739

Třebíč, , Czechia

Site Status

Site Reference ID/Investigator# 40970

Třinec, , Czechia

Site Status

Site Reference ID/Investigator# 40971

Třinec, , Czechia

Site Status

Site Reference ID/Investigator# 41200

Třinec, , Czechia

Site Status

Site Ref # / Investigator 40955

Turnov, , Czechia

Site Status

Site Reference ID/Investigator# 40959

Uherské Hradiště, , Czechia

Site Status

Site Reference ID/Investigator# 41182

Uherské Hradiště, , Czechia

Site Status

Site Reference ID/Investigator# 40906

Ústí nad Labem, , Czechia

Site Status

Site Reference ID/Investigator# 41116

Ústí nad Labem, , Czechia

Site Status

Site Reference ID/Investigator# 40950

Valašské Meziříčí, , Czechia

Site Status

Site Reference ID/Investigator# 40813

Vyškov, , Czechia

Site Status

Site Reference ID/Investigator# 41105

Vyškov, , Czechia

Site Status

Site Ref # / Investigator 41115

Zábřeh, , Czechia

Site Status

Site Reference ID/Investigator# 41186

Zdar, , Czechia

Site Status

Site Reference ID/Investigator# 42084

Zdar, , Czechia

Site Status

Site Reference ID/Investigator# 44895

Zlonice, , Czechia

Site Status

Site Reference ID/Investigator# 40916

Žamberk, , Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P12-161

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CKD-828 (40/5mg) Pharmacokinetic Study
NCT01340131 COMPLETED PHASE1